The HLA-B27/CD3 Detection Kit is a specialized tool designed for the precise detection of HLA-B27 antigen expression on lymphocytes using flow cytometry. This kit is essential for clinical laboratories and research institutions focusing on autoimmune diseases and immune system disorders. It offers a reliable and efficient method for identifying HLA-B27, which is crucial for diagnosing and managing conditions like ankylosing spondylitis.
1. The HLA-B27/CD3 Detection Kit is characterized by its high sensitivity and specificity, ensuring accurate detection of HLA-B27 antigen. The dual-color antibody reagent allows for simultaneous detection of HLA-B27 and CD3, providing a comprehensive analysis of lymphocyte populations.
2. The kit includes HLA-B27-FITC/CD3-PerCP dual-color antibody reagent and hemolysin (10×). These components are carefully formulated to ensure optimal performance in flow cytometry, providing clear and distinct fluorescence signals for accurate data interpretation.
3. This kit is primarily used in clinical laboratories for the diagnosis of HLA-B27-related conditions. It is also valuable in research settings for studying the role of HLA-B27 in autoimmune diseases and immune system regulation.
The HLA-B27/CD3 Detection Kit, also known as the Flow Cytometry HLA-B27 Kit, is a vital tool in both clinical and research settings. Its high sensitivity and specificity make it indispensable for diagnosing HLA-B27-related conditions, while its dual-color antibody reagent ensures comprehensive and accurate results.
The HLA-B27/CD3 Detection Kit offers high sensitivity and specificity for detecting HLA-B27 antigen expression on lymphocytes. It is designed for use with flow cytometry, providing reliable and accurate results.
1. The kit features a dual-color antibody reagent that allows for simultaneous detection of HLA-B27 and CD3, providing a comprehensive analysis of lymphocyte populations.
2. The included hemolysin (10×) ensures efficient red blood cell lysis, enhancing the clarity of fluorescence signals in flow cytometry.
3. The kit is optimized for use with a wide range of flow cytometry instruments, ensuring compatibility and ease of use in various laboratory settings.
4. The high sensitivity of the kit ensures accurate detection of low levels of HLA-B27 antigen, making it suitable for both clinical and research applications.
5. The kit provides clear and distinct fluorescence signals, allowing for easy data interpretation and reliable results.
The HLA-B27/CD3 Detection Kit stands out for its high sensitivity, specificity, and ease of use. Its dual-color antibody reagent and optimized components make it a reliable choice for detecting HLA-B27 antigen expression in both clinical and research settings.
The HLA-B27/CD3 Detection Kit is widely used in clinical laboratories for diagnosing HLA-B27-related conditions, such as ankylosing spondylitis. It is also valuable in research for studying autoimmune diseases.
1. In clinical settings, the kit is used to diagnose HLA-B27-related conditions, such as ankylosing spondylitis, reactive arthritis, and other autoimmune diseases.
2. The kit is also used in research to study the role of HLA-B27 in the immune system and its association with various autoimmune disorders.
3. The high sensitivity of the kit makes it suitable for detecting low levels of HLA-B27 antigen, which is crucial for early diagnosis and management of HLA-B27-related conditions.
4. The kit is used in flow cytometry to analyze lymphocyte populations, providing valuable insights into immune system function and regulation.
5. The kit is also used in clinical trials to evaluate the efficacy of new treatments for HLA-B27-related conditions.
The HLA-B27/CD3 Detection Kit is a versatile tool in both clinical and research settings. Its high sensitivity and specificity make it invaluable for diagnosing HLA-B27-related conditions and studying the immune system's role in autoimmune diseases.
When purchasing the HLA-B27/CD3 Detection Kit, consider product parameters, types, budget, and usage scenarios to ensure it meets your laboratory's needs.
1. Product parameters: Ensure the kit's sensitivity, specificity, and compatibility with your flow cytometry instrument meet your laboratory's requirements.
2. Product types: Choose between different kit sizes and configurations based on your laboratory's volume and frequency of use.
3. Budget: Consider the cost of the kit, including any additional reagents or equipment needed for optimal performance.
4. Usage scenarios: Evaluate the kit's suitability for your specific clinical or research applications, ensuring it aligns with your laboratory's goals and objectives.
Purchasing the HLA-B27/CD3 Detection Kit requires careful consideration of product parameters, types, budget, and usage scenarios. By evaluating these factors, you can ensure the kit meets your laboratory's needs and provides reliable results.
When using the HLA-B27/CD3 Detection Kit, follow proper handling and storage procedures to ensure accurate results and maintain kit integrity.
1. Always wear appropriate personal protective equipment (PPE) when handling the kit components to avoid contamination and ensure safety.
2. Store the kit components at the recommended temperature to maintain their stability and performance.
3. Follow the manufacturer's instructions for preparing and using the kit components to ensure accurate and reliable results.
4. Avoid exposing the kit components to direct sunlight or extreme temperatures, as this may affect their performance.
5. Dispose of used kit components according to local regulations and laboratory safety protocols to prevent environmental contamination.
Proper handling and storage of the HLA-B27/CD3 Detection Kit are essential for maintaining its integrity and ensuring accurate results. By following the manufacturer's instructions and laboratory safety protocols, you can maximize the kit's performance and reliability.
We have the latest medical device product database in China, which can quickly meet your procurement needs.
Submit your purchase list, and we will reply to your inquiry within half an hour at the earliest.